Investors

M6P Therapeutics, or M6PT, is a life sciences company whose mission is clear and simple: to translate the M6PT innovation into more effective next generation therapies for individuals affected by lysosomal storage disorders (LSDs) – to relieve suffering, to restore health, to increase hope, and to improve lives.

If you are interested in investing in M6PT or learning more about the company, please contact IR@m6ptherapeutics.com.